Literature DB >> 30207691

Honeycomb-Satellite Structured pH/H2O2-Responsive Degradable Nanoplatform for Efficient Photodynamic Therapy and Multimodal Imaging.

Qianqian Sun1, Fei He1, Chunqiang Sun1, Xiangxi Wang1, Chunxia Li2, Jiating Xu1, Dan Yang1, Huiting Bi1, Shili Gai2, Piaoping Yang1.   

Abstract

The oxygen-deprived environment of a solid tumor is still great restriction in achieving an efficient photodynamic therapy (PDT). In this work, we developed a smart pH-controllable and H2O2-responsive nanoplatform with degradable property, which was based on honeycomb manganese oxide (hMnO2) nanospheres loaded with Ce6-sensitized core-shell-shell structured up-conversion nanoparticles (NaGdF4:Yb/Er,Tm@NaGdF4:Yb@NaNdF4:Yb) (abbreviated as hMUC). In the system, the speedy breakup of the as-prepared hMnO2 nanostructures results in release of loaded Ce6-sensitized UCNPs under the condition of H2O2 in acid solution. When exposed to tissue-penetrable 808 nm laser, up-conversion nanoparticles (UCNPs) emit higher-energy visible photons which would be absorbed by Ce6 to yield cytotoxic reactive oxygen species (ROS), thus triggering PDT treatment naturally. Moreover, the in vitro and in vivo experiments demonstrate that hMUC sample with the honeycomb-satellite structure can serve as multimodal bioimaging contrast agent for self-enhanced upconversion luminescence (UCL), magnetic resonance imaging (MRI) and computed tomography (CT) imaging, indicating that the as-prepared hMUC could be used in imaging-guided diagnosis and treatment, which has a potential application in the PDT treatment of tumor.

Entities:  

Keywords:  ROS; bioimaging; honeycomb MnO2; photodynamic therapy; upconversion

Mesh:

Substances:

Year:  2018        PMID: 30207691     DOI: 10.1021/acsami.8b10207

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  12 in total

Review 1.  Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy.

Authors:  Xiaoxia Cai; Qingxia Zhu; Yun Zeng; Qi Zeng; Xueli Chen; Yonghua Zhan
Journal:  Int J Nanomedicine       Date:  2019-10-21

2.  Activatable Hybrid Polyphosphazene-AuNP Nanoprobe for ROS Detection by Bimodal PA/CT Imaging.

Authors:  Mathilde Bouché; Manuel Pühringer; Aitziber Iturmendi; Ahmad Amirshaghaghi; Andrew Tsourkas; Ian Teasdale; David P Cormode
Journal:  ACS Appl Mater Interfaces       Date:  2019-08-01       Impact factor: 9.229

Review 3.  The Advances and Biomedical Applications of Imageable Nanomaterials.

Authors:  Xiaohong Xiang; Doudou Shi; Jianbo Gao
Journal:  Front Bioeng Biotechnol       Date:  2022-07-05

Review 4.  Nanoparticle-Based Paramagnetic Contrast Agents for Magnetic Resonance Imaging.

Authors:  Juan Pellico; Connor M Ellis; Jason J Davis
Journal:  Contrast Media Mol Imaging       Date:  2019-05-05       Impact factor: 3.161

5.  pH- and acoustic-responsive platforms based on perfluoropentane-loaded protein nanoparticles for ovarian tumor-targeted ultrasound imaging and therapy.

Authors:  Jianping Li; Hong Ji; Yong Jing; Shiguang Wang
Journal:  Nanoscale Res Lett       Date:  2020-02-03       Impact factor: 4.703

Review 6.  Recent Advances in Photodynamic Therapy for Deep-Seated Tumors with the Aid of Nanomedicine.

Authors:  Wei-Peng Li; Chia-Jui Yen; Bo-Sheng Wu; Tak-Wah Wong
Journal:  Biomedicines       Date:  2021-01-12

Review 7.  Internally Responsive Nanomaterials for Activatable Multimodal Imaging of Cancer.

Authors:  Zachary T Rosenkrans; Carolina A Ferreira; Dalong Ni; Weibo Cai
Journal:  Adv Healthc Mater       Date:  2020-07-21       Impact factor: 9.933

8.  Self-accelerating H2O2-responsive Plasmonic Nanovesicles for Synergistic Chemo/starving therapy of Tumors.

Authors:  Yao Tang; Yuejia Ji; Chenglin Yi; Di Cheng; Bin Wang; Yun Fu; Yufang Xu; Xuhong Qian; Yahya E Choonara; Viness Pillay; Weiping Zhu; Yunen Liu; Zhihong Nie
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

9.  Cytochrome P450 enzyme-mediated auto-enhanced photodynamic cancer therapy of co-nanoassembly between clopidogrel and photosensitizer.

Authors:  Qiu Wang; Mengchi Sun; Dan Li; Chang Li; Cong Luo; Zhaomeng Wang; Wenjuan Zhang; Zimeng Yang; Yao Feng; Shuang Wang; Zhonggui He; Haotian Zhang; Qiming Kan; Wei Sun; Jin Sun
Journal:  Theranostics       Date:  2020-04-15       Impact factor: 11.556

10.  Tumor Microenvironment-triggered Nanosystems as dual-relief Tumor Hypoxia Immunomodulators for enhanced Phototherapy.

Authors:  Zijun Shen; Junfei Xia; Qingming Ma; Wei Zhu; Zhen Gao; Shangcong Han; Yan Liang; Jie Cao; Yong Sun
Journal:  Theranostics       Date:  2020-07-13       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.